IBM, 23andMe Launch Personalized Medicine Initiatives To Tackle Cancer, Lupus

A targeted cancer treatment project involving IBM’s Watson and a lupus research study led by personal genomics company 23andMe and drug maker Pfizer are two of the latest initiatives seeking to advance the growing field of personalized medicine. Both programs will study people's unique genetic profiles to guide decisions on preventing, diagnosing, and treating gene-linked conditions.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news